Marsh & McLennanMMC
MMC
About: Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
Employees: 85,000
0
Funds holding %
of 6,814 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
99% more first-time investments, than exits
New positions opened: 135 | Existing positions closed: 68
23% more repeat investments, than reductions
Existing positions increased: 612 | Existing positions reduced: 496
3% more funds holding
Funds holding: 1,448 [Q2] → 1,498 (+50) [Q3]
2% more capital invested
Capital invested by funds: $94.3B [Q2] → $96.4B (+$2.1B) [Q3]
1% more call options, than puts
Call options by funds: $359M | Put options by funds: $355M
2.71% less ownership
Funds ownership: 90.67% [Q2] → 87.96% (-2.71%) [Q3]
4% less funds holding in top 10
Funds holding in top 10: 25 [Q2] → 24 (-1) [Q3]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$214
2%
upside
Avg. target
$238
14%
upside
High target
$259
24%
upside
8 analyst ratings
3 positive
38%
4 neutral
50%
1 negative
13%
Keefe, Bruyette & Woods Meyer Shields 65% 1-year accuracy 68 / 105 met price target | 2%upside $214 | Underperform Maintained | 10 Jan 2025 |
JP Morgan Jimmy Bhullar 46% 1-year accuracy 17 / 37 met price target | 12%upside $235 | Neutral Maintained | 3 Jan 2025 |
RBC Capital Scott Heleniak 75% 1-year accuracy 40 / 53 met price target | 20%upside $250 | Outperform Upgraded | 12 Dec 2024 |
Evercore ISI Group David Motemaden 50% 1-year accuracy 8 / 16 met price target | 16%upside $242 | Outperform Reinstated | 25 Nov 2024 |
Barclays Alex Scott 52% 1-year accuracy 37 / 71 met price target | 18%upside $246 | Equal-Weight Maintained | 21 Nov 2024 |
Financial journalist opinion
Based on 6 articles about MMC published over the past 30 days
Positive
Zacks Investment Research
6 days ago
Should You Buy, Sell or Hold Marsh & McLennan Stock at a 7.47X P/B?
MMC is currently aided by strong segmental contribution, margin expansion and inorganic growth initiatives.
Positive
Zacks Investment Research
1 week ago
MMC's Unit Enhances Offerings With Acumen Solutions Acquisition
Marsh & McLennan's unit acquires Acumen Solutions, enhances offering for clients and deepens expertise in key sectors.
Neutral
Business Wire
1 week ago
Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30
NEW YORK--(BUSINESS WIRE)--Marsh McLennan (NYSE: MMC), a global leader in risk, strategy and people, will announce fourth quarter financial results via news release on Thursday, January 30, 2025, before the market opens. The news release will be available on marshmclennan.com. Following the news release, President and CEO John Doyle and CFO Mark McGivney will lead a teleconference with investors at 8:30 a.m. EST. The discussion will include a question-and-answer session. The live audio webcast.
Neutral
Business Wire
1 week ago
Marsh McLennan Agency Acquires Acumen Solutions Group
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Marsh McLennan Agency (MMA), a business of Marsh and a leading provider of business insurance, employee health and benefits, retirement and wealth, and private client insurance solutions across North America, today announced the acquisition of Acumen Solutions Group LLC, a Melville, New York-based full-service insurance agency. Terms of the acquisition were not disclosed. Founded in 2012, Acumen provides customized insurance programs to businesses and indivi.
Neutral
Zacks Investment Research
1 week ago
Zacks Industry Outlook Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson
Brown and Brown, Marsh & McLennan, Arthur J. Gallagher & Co and Willis Towers Watson have been highlighted in this Industry Outlook article.
Positive
Zacks Investment Research
1 week ago
4 Stocks to Watch From the Prospering Insurance Brokerage Industry
Higher demand for insurance products, strategic acquisitions and the adoption of technology should drive the performance of Zacks Insurance Brokerage industry players like BRO, MMC, AJG and WTW.
Neutral
Business Wire
1 month ago
Despite Economic Uncertainty, US Employers Maintain Elevated Compensation Budgets for 2025, According to Mercer
NEW YORK--(BUSINESS WIRE)--Today, Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people, released the results of the November 2024 Mercer QuickPulse™ US Compensation Planning Survey. According to the survey of more than 850 US organizations, employers are planning to raise their compensation budgets by 3.3% for merit increases and 3.7% for t.
Positive
Zacks Investment Research
1 month ago
Here's Why Investors Should Hold Marsh & McLennan Stock for Now
MMC is currently aided by strong segmental contribution, solid retention rates and tactical deployment of capital.
Positive
Market Watch
1 month ago
15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season
Other companies whose consensus 2025 revenue estimates have increased the most include BlackRock and Coterra Energy.
Neutral
Newsfile Corp
1 month ago
Octaviant Financial Announces Strategic Initiative with Starr Insurance
New Brunswick, New Jersey--(Newsfile Corp. - November 21, 2024) - Octaviant Financial, Inc. (OFX), a recognized innovator in drug warranty and payment models, announced today that Starr Insurance will join Octaviant and Marsh, the world's leading insurance broker and risk advisor, in offering drug warranty services that enable pharmaceutical companies to stand behind the effectiveness of high-cost therapies. Octaviant will provide its drug warranties under the terms of the partnership through its subsidiary, Actuaria Insurance Services LLC.
Charts implemented using Lightweight Charts™